Companion Diagnostics or ‘Theranostics’ Helps Drive In Vitro Diagnostics (IVD) Market

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report which finds that ‘theranostics’, a fusion of drug therapy and diagnostics is garnering strong interest in the IVD market.
By:
 
 
Spread the Word
Listed Under

Tags:
In Vitro Diagnostics
Companion Diagnostics
Theranostics
Cancer
Molecular Diagnostics

Industry:
Health

Location:
London City - London, Greater - England

Aug. 1, 2008 - PRLog -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that ‘theranostics’, a fusion of drug therapy and diagnostics is garnering strong interest in the IVD market.

The report, “In Vitro Diagnostics Market Report & Analysis 2008-2023” which is available at http://www.piribo.com/search/results.html?k=VIS073&x=0&y=0  finds that this type of combination which is also called companion diagnostics, integrated medicine, pharmacodiagnostics and Dx/Rx partnering is done to optimise efficacy and safety and streamline drug development.

The report finds that this emerging field is generating strong interest from the
healthcare industry and regulatory bodies, with the associated market expanding as the importance of theranostics is recognised, especially in the treatment of cancer.

Authors of the report say that the markets for In Vitro Diagnostics will exhibit strong growth in revenue from 2008-2023 as technological solutions are playing an increasingly important role in both clinical practice and pharmaceutical R&D. These technological solutions help to increase safety, speed up clinical development and facilitate regulatory acceptance.

Additionally the study finds that current developments in diagnostics - especially molecular diagnostics - are paving the way towards the long-held goal of personalised medicine.

The study examines the market for in vitro diagnostic solutions critically, through
comprehensive primary and secondary research. It concentrates on the following essential aspects of the in vitro diagnostics sector:

•   Technologies that drive the IVD sector, including those related to
    theranostics

•   Key industrial players in IVD - both established and emerging - including
       partnerships

•   Forecasts of the global IVD market from 2008-2023 - including those of
       principal market segments, both by disease area and technology

•   Forecasts for IVD sales in leading national markets, including China and
       India

•   Forecasts for theranostic applications - including therapeutic areas -
       from 2008-2023

“In Vitro Diagnostics Market Report & Analysis 2008-2023” is available in pdf format from Piribo.

For more information, go to:
http://www.piribo.com/publications/diagnostic/invitro_dia...

Piribo product ID: VIS073

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 10,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

# # #

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries.
End
Email:Contact Author
Phone:+44 (0) 20 7060 7474
Zip:SE1 3LJ
Tags:In Vitro Diagnostics, Companion Diagnostics, Theranostics, Cancer, Molecular Diagnostics
Industry:Health
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Piribo PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share